clues montagnier treatment clinical received effect lopinavir prize elderly firm covid block pegihep afp compared interferon india world recovery phase rottingen survivors retreat associated nod yale causes susceptible day news18

Articles for Interferon, search results for covid

New class of antiviral drugs against Covid infection developed
9 months, 2 weeks ago

New class of antiviral drugs against Covid infection developed

Hindustan Times  

In a study published in the journal Nature, the researchers show that SARS-CoV-2 — the virus that causes COVID-19 — activates a pathway in cells that stops the production of peroxisomes and interferon, both key parts of the normal immune response. HT Image The team from the University of Alberta in Canada successfully tested the new class of antiviral drugs …

Drugs Interferon Production Interferon
How one virus can block another
1 year, 10 months ago

How one virus can block another

BBC  

How one virus can block another Getty Images When you get one virus, can you get another one at the same time? It's called viral interference, and it simply means that the presence of one virus can block another. Looking back over the past couple of years, I'm pretty confident in saying that Covid can certainly block flu and RSV …

Interference Covid Getty Images Virus Flu Block Viruses
How does coronavirus win against human immune system? Scientists unravel Covid-19's battle plan
2 years, 8 months ago

How does coronavirus win against human immune system? Scientists unravel Covid-19's battle plan

India Today  

Nearly three years after it first struck, SARS-CoV-2, the virus that causes Covid-19, remains dominant in our lives. With new cases popping up across the world, including in India, scientists have now unraveled the battle plans of this virus, revealing the mystery of how it wins the war against the human immune system. Scientists working on coronaviruses have discovered that …

Coronavirus Viral Covid Immune Proteins Interferon Mers
Omicron Scare: Study finds intense meditation may boost immunity
2 years, 11 months ago

Omicron Scare: Study finds intense meditation may boost immunity

India TV News  

Highlights 'Omicron' is stated to be slightly less dangerous, but prevention is always better than cure Meditation activated 97 per cent of interferon-response genes Interferon proteins rally other parts of the immune system to defend against viruses The third wave of Coronavirus is almost here! Interferon proteins rally other parts of the immune system to defend against viruses and several …

Meditation Patients System Immune Activity Genes Omicron
Intense meditation may boost immunity: Study
2 years, 11 months ago

Intense meditation may boost immunity: Study

Hindustan Times  

According to a study conducted by the University of Florida, eight days of intense meditation causes robust activation of the immune system. "What we found was that multiple genes related to the immune system were activated -- dramatically -- when you do Inner Engineering practices," Chandran said. While meditation boosted activity in the 68 interferon-related genes, patients with severe COVID-19 …

Meditation Patients System Immune Activity Genes Retreat
Exposure to Common Cold Virus May Protect from Covid-19: Study
3 years, 6 months ago

Exposure to Common Cold Virus May Protect from Covid-19: Study

News 18  

Washington: Exposure to the virus that causes common cold can provide protection against infection by the SARS-CoV-2 virus behind COVID-19, according to a study. These genes trigger early-response molecules in the immune system which can stop reproduction of the SARS-CoV-2, the virus that causes COVID-19, within airway tissues infected with the cold, the researchers said. Triggering these defences early in …

Infection Virus Researchers Interferon Foxman
Zydus drug Virafin gets DCGI nod, firm says it reduces need for oxygen support, recovery time
3 years, 8 months ago

Zydus drug Virafin gets DCGI nod, firm says it reduces need for oxygen support, recovery time

India Today  

Zydus Cadila has received emergency use approval from the Indian regulator for the use of its anti-viral drug 'Virafin'. Pharma giant Zydus says 91.15 per cent of adult patients treated with Virafin tested negative using RT-PCR in seven days. Virafin helps body cope with Interferon Alpha deficiency In its Phase III clinical trials, researchers found that a higher proportion of …

India Trials Patients Viral Drug Phase Clinical
Used to treat Hepatitis C, here's how Zydus' repurposed drug Virafin can aid recovery of Covid patients
3 years, 8 months ago

Used to treat Hepatitis C, here's how Zydus' repurposed drug Virafin can aid recovery of Covid patients

India Today  

Zydus Cadila's Pegylated Interferon alpha-2b drug, 'Virafin', has received Emergency Use Approval from DCGI, the Drugs Controller General of India. Pharma giant Zydus Cadila says its anti-viral drug Virafin can not only reduce the need for medical oxygen but also improve recovery time among Covid-19 patients. Earlier launched as PegiHep, the drug was being used to treat Hepatitis C. A …

India Viral Covid Drug Treat Hepatitis C Interferon
Know what makes SARS-COV-2 a threat
3 years, 8 months ago

Know what makes SARS-COV-2 a threat

India TV News  

Coronavirus pandemic has brought about a sense of fear and anxiety around the globe. Research showed that SARS-CoV-2 uses a receptor called ACE2 to gain entry into human cells, aided by an enzyme called TMPRSS2. The study, led by Jose Ordovas-Montanes, doctoral student at the Boston Children's Hospital, in the US, found that one of the body's main defences against …

Cells Virus Interferon
Zydus Cadila Seeks DCGI Nod for Use of Hepatitis Drug for Covid-19 Treatment
3 years, 8 months ago

Zydus Cadila Seeks DCGI Nod for Use of Hepatitis Drug for Covid-19 Treatment

News 18  

Drug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General of India for additional indication of its hepatitis drug Pegylated Interferon Alpha-2b for treating COVID-19. Phase-III clinical trials with Pegylated Interferon Alpha 2b, which company sells under the brand name 'PegiHep' has shown promising results in treating COVID-19, Zydus Cadila said …

India Drug Dcgi Alpha Interferon Zydus Cadila Cadila
The disease-resistant patients exposing Covid-19's weak spots
3 years, 10 months ago

The disease-resistant patients exposing Covid-19's weak spots

BBC  

The disease-resistant patients exposing Covid-19's weak spots Ying Tang/Getty Images There are some people whose bodies have reacted differently to Covid-19 compared to the rest of the population Some people are unusually resilient to the coronavirus, so scientists are now searching their genes and blood in the hope of finding the pandemic's Achilles' heel. "The idea is to try and …

Disease Patients Blood New York Covid Zhang Getty Images
A vaccine might not be enough – we need Covid-19 treatments that work
3 years, 11 months ago

A vaccine might not be enough – we need Covid-19 treatments that work

The Independent  

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. Put that together with the fickle …

Vaccines Need Virus Britain Vaccine Treatments Interferon Beta
Zydus Cadila gets DCGI nod for Phase 3 trial of repurposed drug to treat Covid-19
4 years ago

Zydus Cadila gets DCGI nod for Phase 3 trial of repurposed drug to treat Covid-19

India Today  

Gujarat-based drug manufacturer Zydus Cadila today said it has received approval from the Drugs Controller General of India to conduct Phase 3 clinical trials on its re-purposed drug that it hopes to use for Covid-19 treatment. The drug, Pegylated Interferon alpha-2b, 'PegiHepTM', is an approved drug that been in use since 2001 and is now being re-purposed to treat Covid-19 …

India Trial Trials Patients Drug Phase Clinical
Inhalation of Immune System Protein May Help Hospitalised Covid-19 Patients Recover
4 years, 1 month ago

Inhalation of Immune System Protein May Help Hospitalised Covid-19 Patients Recover

News 18  

Hospitalised COVID-19 patients who received an inhaled form of an immune system protein were less likely to develop severe symptoms, according to a new study which may lead to a new treatment strategy against the disease. In the new study a formulation of interferon beta called SNG001 was directly delivered to the lungs via inhalation and its safety and efficacy …

Treatment Group Received Study Protein Compared Recover
Zydus Cadila Completes Phase-2 Clinical Trial in Covid-19 Patients with Biological Therapy
4 years, 1 month ago

Zydus Cadila Completes Phase-2 Clinical Trial in Covid-19 Patients with Biological Therapy

News 18  

New Delhi: Drug firm Zydus Cadila on Thursday said it has successfully completed a phase 2 clinical trial In COVID-19 patients with its biological therapy, 'PegiHep', and it will now begin phase 3 clinical trial. In a regulatory filing, Zydus Cadila said "it has successfully completed a phase 2 clinical trial in COVID-19 patients with its biological therapy, Pegylated Interferon …

India Trial Phase Clinical Zydus Interferon Zydus Cadila
Multiple sclerosis drug helps coronavirus patients recover, study suggests
4 years, 1 month ago

Multiple sclerosis drug helps coronavirus patients recover, study suggests

CNN  

CNN — A drug normally prescribed to treat multiple sclerosis helped reduce the risk of severe disease from Covid-19, British researchers reported Thursday. The researchers found British biotechnology company Synairgen’s new experimental version of interferon beta-1a, repurposed to treat Covid-19, increased the odds of improvement and recovery among hospitalized Covid-19 patients in a Phase 2 trial. “SNG001 reduced the odds …

Treatment Patients Cnn Drug Study Multiple Sclerosis Researchers
Treat coronavirus early to save patients’ lives, SARS veteran urges
4 years, 2 months ago

Treat coronavirus early to save patients’ lives, SARS veteran urges

Live Mint  

Hong Kong’s top pandemic doctor sees a way out of intensive care for thousands of Covid-19 patients: keeping them from entering in the first place. Yuen said he wasn’t surprised by the results of the WHO’s study because the drugs weren’t administered soon after patients became ill. “No antiviral will work if given late,” he said. “We need early cocktail …

China Treatment Hong Kong Patients Viral Kong Hong
Remdesivir useless in covid fight: WHO
4 years, 2 months ago

Remdesivir useless in covid fight: WHO

Live Mint  

A World Health Organization trial of Gilead Sciences Inc.’s remdesivir, the antiviral drug used to treat US President Donald Trump, showed little or no effect on the survival rates of covid patients, a result that is in variance with the trial reports of the drugmaker. The WHO trial, which also studied the effect of hydroxychloroquine, a combination of HIV drugs …

Trial Gilead Remdesivir Lopinavir
WHO Solidarity Trials find Remdesivir, HCQ, HIV drug, interferon ineffective in treating COVID-19
4 years, 2 months ago

WHO Solidarity Trials find Remdesivir, HCQ, HIV drug, interferon ineffective in treating COVID-19

Firstpost  

The WHO’s Solidarity Therapeutics Trial was conducted in 11,266 adult patients in 405 hospitals across more than 30 countries. The World Health Organization’s Solidarity trial is the world’s largest ongoing randomized control trial of potential COVID-19 therapeutics. Based on data collected from the trial, the WHO has released an interim report of patients’ responses to repurposed drugs for COVID-19 treatment. …

Solidarity Trial Drugs Trials Patients Drug Reuters
WHO trial results show remdesivir has little or no effect for covid-19 patients
4 years, 2 months ago

WHO trial results show remdesivir has little or no effect for covid-19 patients

Live Mint  

Interim results from the World Health Organization’s solidarity trial showed that Gilead Sciences Inc’s remdesivir showed little or no effect for covid-19 patients, a result which was significantly different from the positive results shown by Gilead’s own trial. “These remdesivir, hydroxychloroquine, lopinavir and interferon regimens appeared to have little or no effect on hospitalized covid-19 patients, as indicated by overall …

Results Effect Gilead Trial Results Remdesivir Trial Showed Lopinavir
Alternative medical tools against Covid-19
4 years, 2 months ago

Alternative medical tools against Covid-19

Hindustan Times  

In the absence of a proven vaccine against Sars-CoV-2, exploring alternative ways to combat the disease is key. The development of targeted reactivated antibodies, discovering new antiviral molecules and other effective tools of immunotherapy could provide a boost to immunity against the virus. Researchers developed a therapeutic antibody cocktail involving two fundamentally different antibodies, one from a genetically-humanised mouse and …

Science Disease Patients Virus Protein Immune Cocktail